Analyst Ratings for Amneal Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Amneal Pharmaceuticals (NYSE:AMRX) has received 4 bullish ratings from analysts in the last quarter, with an average 12-month price target of $5.5. This average price target has increased by 49.86% over the past month.
September 06, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amneal Pharmaceuticals has received positive analyst ratings, which could potentially boost its stock price in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Amneal Pharmaceuticals has received positive ratings, which could potentially lead to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100